Preferred Label : azelastine hydrochloride;
UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;
CAS number : 79307-93-0; 0L591QR10I;
Is substance : O;
UNII : 0L591QR10I;
InChIKey : YEJAJYAHJQIWNU-UHFFFAOYSA-N;
Origin ID : M0314382;
UMLS CUI : C0771004;
CISMeF manual mappings
- Exact mapping(s) to DCI
- Related record
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3497032/fr/azelastine-chlorhydrate-/-fluticasone-propionate-eg-chlorhydrate-d-azelastine-/-propionate-de-fluticasone-rhinite-allergique
2024
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
rhinitis, allergic, seasonal
fluticasone, combinations
administration, intranasal
histamine H1 antagonists, non-sedating
anti-inflammatory agents
evaluation of the transparency committee
azelastine hydrochloride
Fluticasone
rhinitis, allergic, perennial
Fluticasone Propionate
azelastine
---
https://www.has-sante.fr/jcms/p_3305330/fr/chlorhydrate-d-azelastine-mylan-medical-1-5-mg/ml-chlorhydrate-d-azelastine
2021
false
false
false
France
evaluation of the transparency committee
azelastine
azelastine hydrochloride
registries
azelastine hydrochloride
---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=69043954
2016
false
false
false
France
French
summary of product characteristics
package leaflet
drug combinations
administration, intranasal
nasal sprays
histamine H1 antagonists, non-sedating
anti-inflammatory agents
Fluticasone Propionate
azelastine hydrochloride
fluticasone, combinations
rhinitis, allergic, seasonal
rhinitis, allergic, perennial
drug interactions
pregnancy
breast feeding
Fluticasone Propionate
azelastine hydrochloride
drug evaluation, preclinical
anti-inflammatory agents
histamine H1 antagonists, non-sedating
anti-allergic agents
anti-allergic agents
Fluticasone
suspension, nos
azelastine
propionate
azelastine hydrochloride
nose, nos
Fluticasone Propionate
propionates
suspensions
azelastine hydrochloride
Fluticasone
azelastine
Fluticasone
azelastine
phthalazines
phthalazines
phthalazines
---
Summary Basis of Decision (SBD) for Dymista
137 mcg azelastine hydrochloride and 50 mcg fluticasone propionate per metered spray,
suspension for nasal spray, intranasal
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00184
2014
false
false
false
Canada
French
English
drug combinations
azelastine hydrochloride
azelastine hydrochloride
administration, intranasal
nasal sprays
rhinitis, allergic, seasonal
histamine H1 antagonists, non-sedating
histamine H1 antagonists, non-sedating
anti-allergic agents
anti-allergic agents
fluticasone, combinations
anti-inflammatory agents
anti-inflammatory agents
drug approval
canada
adult
adolescent
drug evaluation
risk assessment
treatment outcome
corticosteroid therapy
Fluticasone Propionate
Fluticasone Propionate
drug information
azelastine
azelastine
phthalazines
phthalazines
Fluticasone
Fluticasone
---
http://www.has-sante.fr/portail/jcms/c_1725332/fr/dymista
2014
false
true
false
France
French
drug combinations
azelastine hydrochloride
azelastine hydrochloride
administration, intranasal
nasal sprays
rhinitis, allergic, seasonal
histamine H1 antagonists, non-sedating
histamine H1 antagonists, non-sedating
anti-allergic agents
anti-allergic agents
fluticasone, combinations
anti-inflammatory agents
anti-inflammatory agents
adult
adolescent
treatment outcome
child
guidelines for drug use
evaluation of the transparency committee
rhinitis, allergic, perennial
corticosteroid therapy
Fluticasone Propionate
Fluticasone Propionate
azelastine
azelastine
phthalazines
phthalazines
Fluticasone
Fluticasone
---
